A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation - ScienceDirect
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
AL Amyloidosis | Amyloidosis Foundation
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review - ScienceDirect
Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study - The Lancet Haematology
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - The FEBS Journal - Wiley Online Library
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science